Comments on: Hikma Pharmaceutical enjoys 9% revenue growth and strong momentum across the business https://ukinvestormagazine.co.uk/hikma-pharmaceutical-enjoys-9-revenue-growth-and-strong-momentum-across-the-business/ UK Investor Magazine provides breaking financial news and investment ideas Thu, 17 Mar 2022 21:00:04 +0000 hourly 1 https://wordpress.org/?v=6.9.4 By: Hikma's revenue grows 9% on strong performance - Swave Digest https://ukinvestormagazine.co.uk/hikma-pharmaceutical-enjoys-9-revenue-growth-and-strong-momentum-across-the-business/#comment-17314 Thu, 17 Mar 2022 21:00:04 +0000 https://ukinvestormagazine.co.uk/?p=46078#comment-17314 […] Generics saw a revenue growth of 10% in the segment to $820bn. The growth mainly came from recently launched products such as Kloxxado and generic Advair Diskus. […]

]]> By: Hikma’s revenue grows 9% on strong performance – Ali Tech https://ukinvestormagazine.co.uk/hikma-pharmaceutical-enjoys-9-revenue-growth-and-strong-momentum-across-the-business/#comment-17312 Thu, 17 Mar 2022 17:46:00 +0000 https://ukinvestormagazine.co.uk/?p=46078#comment-17312 […] Generics saw a revenue growth of 10% in the segment to $820bn. The growth mainly came from recently launched products such as Kloxxado and generic Advair Diskus. […]

]]>